WASHINGTON, Jan 16 (Reuters) - The U.S. Supreme Court agreed ‌on ​Friday to hear a patent dispute ‌involving Amarin Pharma's ...

On Friday, the U.S. Supreme Court granted certiorari to a petition filed by patent owner Hikma Pharmaceuticals, taking up ...

Health policy in the United States in 2025 featured a series of executive and agency actions that were defined not just what ...

It has long been ignored that the Biden administration de facto guaranteed legal abortion in all 50 states just 15 days after ...

The Senate’s health committee convened its first hearing of the year on the efficacy of the chemical abortion drug ...

Internal FDA reviews examined in the JAMA study show that the agency repeatedly confirmed that mifepristone is safe. One ...

Makary has stressed that while a review of the abortion pill is ongoing, the FDA is unable to fully respond due to pending ...

Since the U.S. Supreme Court rolled back the constitutional right to abortion in 2022, nearly half of U.S. states have banned ...

More than two dozen states now have laws or policies restricting transgender student athletes from joining teams that don’t match their sex at birth. We look at the constitutional questions these ...

Law-school data shows that racial preferences have diminished since the justices’ 2023 decision.

The Supreme Court seems likely to uphold state laws barring transgender girls and women from playing on school athletic teams ...